Hyun Soon Sohn
Overview
Explore the profile of Hyun Soon Sohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seong J, Kim J, Kim H, Sohn H
Front Pharmacol
. 2021 Oct;
12:689885.
PMID: 34650428
This study compared dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, and dipeptidyl peptidase-4 inhibitors (DPP-4i) with regard to cardiovascular (CV) event incidence and direct medical costs during type 2 diabetes treatment....
2.
Lee N, Kim M, Sohn H
Int J Clin Pharm
. 2020 Aug;
42(6):1539.
PMID: 32803557
In the original publication of the article the order of authors has been interchanged and now the same has been provided correctly in this correction.
3.
Kim J, Jang E, Park J, Sohn H
PLoS One
. 2020 Jul;
15(7):e0235163.
PMID: 32730257
Objectives: The purpose of this study was to reconfirm the association between the risk of fracture and proton pump inhibitor use and to establish evidence for defining a high-risk group...
4.
Seong J, Kim J, Kim H, Sohn H
Cardiovasc Diabetol
. 2020 Jun;
19(1):95.
PMID: 32571319
Background: Dapagliflozin is one of the novel glucose-lowering agents, which has recently been reported to reduce the risk of hospitalization for heart failure (hHF). The present study aimed to compare...
5.
Kim M, Lee N, Sohn H
Int J Clin Pharm
. 2020 Apr;
42(2):677-684.
PMID: 32266556
Background Assessing and satisfying patient expectation are essential in successful patient-centered communication. Recognizing the gap between patient expectation and perception during pharmacist-patient communication can help to identify communication problems and...
6.
Jang S, Han E, Kang C, Cho H, Sohn H, Lee J
Res Social Adm Pharm
. 2020 Mar;
17(2):419-427.
PMID: 32197921
Background: The National Health Insurance Service in South Korea has conducted a telephone outreach program to improve medication adherence for hypertension and diabetes patients since 2014. Objectives: To evaluate the...
7.
Kim J, Kim M, Park S, Hwang J, Sohn H
Int J Clin Pharmacol Ther
. 2019 Nov;
58(3):166-173.
PMID: 31724531
Objective: Non-calcium containing phosphate binders (non-CPBs) are useful for the treatment of hyperphosphatemia without a concern of hypercalcemia in patients undergoing dialysis. However, due to their relatively high cost, prescribing...
8.
Jang E, Ha J, Im S, Kim M, Sohn H
Clin Drug Investig
. 2019 May;
39(7):625-630.
PMID: 31098835
Background And Objectives: Anti-tumor necrosis factor alpha (anti-TNFα) therapy is key to the treatment of inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD). The objective of...
9.
Park H, Kim S, Sohn H, Kwon J
Clin Drug Investig
. 2018 Oct;
39(1):63-71.
PMID: 30306340
Background And Objective: Polypharmacy, regarded as an indicator of potentially inappropriate medications (PIMs), may lead to a higher risk of serious health consequences in elderly patients with osteoporosis. Thus, this...
10.
Park H, Park J, Sohn H, Kwon J
Drug Saf
. 2017 Jun;
40(11):1109-1118.
PMID: 28634824
Introduction: Published studies on the association between polypharmacy and parkinsonism or Parkinson disease are very limited. Objective: The objective of this study was to investigate whether polypharmacy is associated with...